Back to the list
Congress: ECR25
Poster Number: C-28111
Type: Poster: EPOS Radiologist (scientific)
Authorblock: L. A. Rivera Alcantara, R. K. Kulshrestha; Bristol/UK
Disclosures:
Luz Altagracia Rivera Alcantara: Nothing to disclose
Randeep Kumar Kulshrestha: Nothing to disclose
Keywords: Genital / Reproductive system female, Hybrid Imaging, Oncology, MR, PET-CT, Comparative studies, Diagnostic procedure, Cancer, Education and training
References
  1. Zou, Y., Zhu, S., Kong, Y. et al.Precision matters: the value of PET/CT and PET/MRI in the clinical management of cervical cancer. Strahlenther Onkol (2024). https://doi.org/10.1007/s00066-024-02294-8
  2. Added Value of FDG PET/MRI in Gynecologic Oncology: A Pictorial Review 

    Ziad Tarcha, Katerina S. Konstantinoff, Semra Ince, Tyler J. Fraum, Elizabeth A. Sadowski, Priya R. Bhosale, Paul-Robert Derenoncourt, Maria Zulfiqar, Anup S. Shetty, Maria R. Ponisio, Joyce C. Mhlanga, and Malak Itani

    RadioGraphics 2023 43:8

  3. Evidence-based indications for the use of PET-CT in the United Kingdom 2022 4 The Royal College of Radiologists, Royal College of Physicians, British Nuclear Medicine Society, Administration of Radioactive Substances Advisory Committee
  4. 2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging. 

    Miriam Y. Salib, James H. B. Russell, Victoria R. Stewart, Siham A. Sudderuddin, Tara D. Barwick, Andrea G. Rockall, and Nishat Bharwani

    RadioGraphics 2020 40:6, 1807-1822

  5. Woo S, Atun R, Ward ZJ, Scott AM, Hricak H, Vargas HA. Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis. Eur Radiol. 2020 Oct;30(10):5560-5577. doi: 10.1007/s00330-020-06909-3. Epub 2020 May 15. PMID: 32415584; PMCID: PMC8353650.
  6. 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging. 

    Susanna I. Lee and Mostafa Atri

    Radiology 2019 292:1, 15-24

  7. Viswanathan C, Faria S, Devine C, Patnana M, Sagebiel T, Iyer RB, Bhosale PR. [18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer. PET Clin. 2018 Apr;13(2):165-177. doi: 10.1016/j.cpet.2017.11.004. Epub 2018 Feb 3. PMID: 29482748; PMCID: PMC5996999.
  8. Cervical Cancer Staging: A Resident’s Primer: Women’s Imaging. Anish Raithatha, Ioanna Papadopoulou, Victoria Stewart, Tara D. Barwick, Andrea G. Rockall, and Nishat Bharwani. RadioGraphics 2016 36:3, 933-934
  9. Post–Radiation Therapy Imaging Appearances in Cervical Carcinoma. Ioanna Papadopoulou, Victoria Stewart, Tara D. Barwick, Won-Ho Edward Park, Neil Soneji, Andrea G. Rockall, and Nishat Bharwani. 

    RadioGraphics 2016 36:2, 538-553

  10. Agrawal A, Rangarajan V. Appropriateness criteria of FDG PET/CT in oncology. Indian J Radiol Imaging. 2015 Apr-Jun;25(2):88-101. doi: 10.4103/0971-3026.155823. PMID: 25969632; PMCID: PMC4419439.
  11. Herrera FG, Prior JO. The role of PET/CT in cervical cancer. Front Oncol. 2013 Feb 26;3:34. doi: 10.3389/fonc.2013.00034. PMID: 23549376; PMCID: PMC3581867.
  12. PET/CT Evaluation of Cervical Cancer: Spectrum of Disease. Hongju Son, Arpakorn Kositwattanarerk, Monica P. Hayes, Linus Chuang, Jamal Rahaman, Sherif Heiba, Josef Machac, Konstantin Zakashansky, and Lale Kostakoglu. RadioGraphics 2010 30:5, 1251-1268
  13. https://radiopaedia.org/articles/cervical-carcinoma-1?lang=us
  14. The Radiology Assistant : Cervical Cancer - MR staging
GALLERY